February 23, 2017 6:59 PM ET


Company Overview of MacroGenics, Inc.

Company Overview

MacroGenics, Inc., a biopharmaceutical company, focuses on discovering and developing antibody-based therapeutics for the treatment of cancer primarily by modulating the human immune system, as well as various autoimmune disorders and infectious diseases. Its advanced clinical product candidate is Margetuximab, a monoclonal antibody that is in Phase III clinical trial, which targets human epidermal growth factor receptor 2-expressing tumors, including certain types of breast and gastroesophageal cancers. The company also develops Enoblituzumab, an antibody that is in Phase 1 clinical trial as monotherapy in multiple dose expansion cohorts; MGD006, a DART molecule that targets CD123 and CD3; ...

9640 Medical Center Drive

Rockville, MD 20850

United States

Founded in 2000

269 Employees





Key Executives for MacroGenics, Inc.

Chief Executive Officer, President and Director
Age: 64
Total Annual Compensation: $523.0K
Chief Financial Officer, Senior Vice President and Corporate Secretary
Age: 49
Total Annual Compensation: $336.5K
Chief Medical Officer and Senior Vice President of Clinical Development
Age: 54
Total Annual Compensation: $380.8K
Senior Vice President and General Counsel
Age: 43
Total Annual Compensation: $357.7K
Chief Scientific Officer and Senior Vice President of Research
Age: 62
Total Annual Compensation: $353.0K
Compensation as of Fiscal Year 2015.

MacroGenics, Inc. Key Developments

MacroGenics Announces Executive Appointments

MacroGenics, Inc. appointed Karen J. Ferrante, M.D., and Scott Jackson to fill the newly created vacancies. Dr. Ferrante will serve on the Nominating & Corporate Governance Committee of the Board and Mr. Jackson will serve on the Compensation Committee of the Board. Dr. Ferrante most recently served as Chief Medical Officer and Head of Research and Development at Tokai Pharmaceuticals and brings over 20 years of oncology drug development experience to the Board. Prior to Tokai, Dr. Ferrante held several senior level positions at Millennium Pharmaceuticals and parent company Takeda Pharmaceuticals, including Oncology Therapeutic Area Head, Takeda Cambridge Site Head and Chief Medical Officer. Dr. Ferrante has also previously held positions of increasing responsibility at Pfizer Global Research and Development and Bristol-Myers Squibb. Mr. Jackson served as Chief Executive Officer and as a member of the Board of Directors of Celator Pharmaceuticals, Inc. from April 2008 until July 2016, when the company was acquired by Jazz Pharmaceuticals plc. Mr. Jackson has more than 25 years of experience in the pharmaceutical and biotechnology industry and has held positions of increasing responsibility in sales, marketing and commercial development at Eli Lilly & Co., SmithKline Beecham, ImClone Systems Inc., Centocor Inc.

MacroGenics, Inc. Presents at The Leerink Partners 6th Annual Global Healthcare Conference, Feb-16-2017 09:30 AM

MacroGenics, Inc. Presents at The Leerink Partners 6th Annual Global Healthcare Conference, Feb-16-2017 09:30 AM. Venue: Lotte New York Palace, 455 Madison Ave., New York, New York, United States. Speakers: Scott Koenig, Chief Executive Officer, President and Director.

MacroGenics, Inc. Presents at SunTrust Robinson Humphrey 2017 Orphan Drug Day, Feb-14-2017

MacroGenics, Inc. Presents at SunTrust Robinson Humphrey 2017 Orphan Drug Day, Feb-14-2017 . Venue: JW Marriott Essex House New York, 160 Central Park South (b/w 58th & 59th Street), New York, NY 10019, United States.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MacroGenics, Inc., please visit www.macrogenics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.